Search

Zoetis Inc

Chiusa

SettoreSettore sanitario

76.62 3.68

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

73.93

Massimo

77.44

Metriche Chiave

By Trading Economics

Entrata

90M

691M

Vendite

206M

2.5B

P/E

Media del settore

12.041

57.371

EPS

1.87

Rendimento da dividendi

2.79

Margine di Profitto

27.998

Dipendenti

14,500

EBITDA

-12M

927M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+23.95% upside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

2.79%

2.23%

Utili prossimi

3 nov 2026

Prossima data del Dividendo

1 set 2026

Prossima data del' Ex Dividendo

30 ott 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-2.2B

30B

Apertura precedente

72.94

Chiusura precedente

76.62

Notizie sul Sentiment di mercato

By Acuity

62%

38%

299 / 340 Classifica in Healthcare

Zoetis Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

18 ago 2026, 23:01 UTC

Zoetis Inc. shares rose slightly in after-market trading, despite remaining below the 20-day moving average and near the lower end of their one-month range.

17 ago 2026, 23:36 UTC

Zoetis Inc shares are lower in after-market hours, following a broader market trend amid rising crude oil prices and geopolitical tensions.

14 ago 2026, 23:06 UTC

Zoetis Inc. shares are higher in after-market trading, recovering from earlier losses. This movement occurs amid broader economic concerns over declining U.S. retail sales.

13 ago 2026, 23:06 UTC

Zoetis Inc. shares moved lower in after-market trading, reflecting a modest decline since Thursday's close. The performance remains within the one-month trading range.

12 ago 2026, 20:01 UTC

News

Zoetis Inc. shares are lower as analysts cut price targets amid broader market pressures. Piper Sandler lowered its target from $90 to $80.

11 ago 2026, 23:36 UTC

Zoetis Inc. shares traded roughly flat in after-market hours, showing minimal change and stability within the middle of its one-month trading range.

10 ago 2026, 23:06 UTC

Correlated Moves
News

Shares of Zoetis Inc. are higher in after-market trading as investor Michael Burry increases his long equity position, citing potential for multi-year stabilization.

8 ago 2026, 00:01 UTC

Zoetis Inc. shares are higher in after-market trading, reflecting gains since Friday's close amid broader market dynamics influenced by recent economic data.

7 ago 2026, 23:01 UTC

Zoetis shares advanced in after-market trading, showing notable activity despite being below the 20-day moving average and near the lower end of its one-month range.

6 ago 2026, 23:26 UTC

News

Zoetis Inc shows a modest advance in after-market trading, now valued at approximately $31.19 billion, ranking as the 298th largest firm by market capitalization.

5 ago 2026, 23:41 UTC

Zoetis Inc. shares declined in after-market trading, remaining below their 20-day moving average despite earlier gains. Asian markets, including the Nikkei 225, performed positively.

4 ago 2026, 19:26 UTC

Zoetis Inc shares are lower today amid unusual volatility, reaching a session low earlier. No specific news was identified to explain the movement.

3 ago 2026, 23:31 UTC

Zoetis Inc shares are higher in after-market trading, continuing positive momentum after three consecutive sessions of gains amid favorable market sentiment.

1 ago 2026, 00:01 UTC

Zoetis Inc shares rose in after-market trading, recovering from an initial dip and reaching a high near the upper end of its one-month range.

31 lug 2026, 23:06 UTC

Zoetis Inc shares are higher in after-market trading, maintaining gains since Friday's close and remaining above the 20-day moving average.

30 lug 2026, 19:03 UTC

Zoetis Inc shares are lower, impacted by a decline in the Pharmaceuticals sub-sector. Earlier in the session, the stock peaked before falling.

29 lug 2026, 22:51 UTC

Zoetis Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline amid broader market volatility.

28 lug 2026, 23:02 UTC

Zoetis Inc shares are higher in after-market trading, reflecting broader market strength amid investor optimism ahead of key earnings reports and the Federal Reserve meeting.

27 lug 2026, 23:16 UTC

News

Zoetis shares are lower in after-market hours following a class action lawsuit alleging securities fraud and reduced profit guidance to between $6.85 and $7.00 per share.

25 lug 2026, 00:01 UTC

Zoetis Inc. shares are trading higher in after-market hours, continuing a positive trend after closing higher for three consecutive sessions.

24 lug 2026, 21:02 UTC

Zoetis Inc shares are higher in after-market trading, rebounding from an initial dip despite a broader market decline influenced by disappointing earnings from Tesla and Alphabet.

23 lug 2026, 20:02 UTC

Zoetis Inc. shares are higher as strength in the pharmaceuticals sub-sector drives upward momentum, contributing to modest gains since Wednesday's close.

22 lug 2026, 21:02 UTC

Zoetis Inc. shares are lower in after-market trading, continuing a trend of five consecutive daily declines amid mixed market performance and rising crude oil prices.

21 lug 2026, 17:51 UTC

News

Zoetis Inc. shares are lower amid scrutiny from a securities fraud class action lawsuit alleging undisclosed market share declines and safety issues with Librela.

20 lug 2026, 23:16 UTC

Zoetis shares traded higher in after-market hours, maintaining stability above Monday's close despite broader market pressures from rising treasury yields.

Confronto tra pari

Modifica del prezzo

Zoetis Inc Previsione

Obiettivo di Prezzo

By TipRanks

23.95% in crescita

Previsioni per 12 mesi

Media 91.67 USD  23.95%

Alto 115 USD

Basso 80 USD

Basato su 12 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Zoetis Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

12 ratings

5

Acquista

7

Mantieni

0

Vendi

Sentiment

By Acuity

299 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat